24 November 2017
News and Views
Links and Services
The latest British Journal of Cancer examines the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer.
The triple drug combination consisting of irinotecan, oxaliplatin and 5-fluorouracil has demonstr
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors